Log In
Print this Print this

ST1 antibody-drug conjugate (ADC)

  Manage Alerts
Collapse Summary General Information
Company Siamab Therapeutics Inc.
DescriptionAntibody-drug conjugate (ADC) composed of a sialosyl-Tn antigen (sTn) antibody and monomethyl auristatin E (MMAE)
Molecular Target Sialosyl-Tn antigen (sTn)
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today